Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

Related news about the opioid crisis and improving patient outcomes
By monitoring vitals during drug use, nurses can administer oxygen and IV fluids to keep patients alive
EMS will work with law enforcement, doctors and public health officials to head off overdose spikes “like a measles outbreak”
We asked EMS1 readers to share their knowledge and use of capnography during patient care
In 2015, 2,590 people in Ohio died of opioid overdoses, which includes heroin, fentanyl, and other prescription overdoses
Some of the patients were found unconscious or experiencing seizures
Officials are increasing Narcan access and reducing opioid prescriptions, but the problem has grown
A total of 32 people from Skid Row have been transported to hospitals this week
Narcan will be provided free of charge by Summit County Public Health
Researchers measured the impact several CPR feedback or prompt devices had on chest compression depth, compression rate recoil and hand position
The musician weighed 112 lbs. when he died in April; an autopsy revealed that the fatal dose would have killed anyone regardless of size
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.